Fortis .. FDA Clearance of Two IND Ap... - Advanced Prostate...

Advanced Prostate Cancer

21,056 members26,262 posts

Fortis .. FDA Clearance of Two IND Applications for Novel Anti-CD46 Therapeutic for Treatment of Late-Stage Prostate Cancer & Multiple M...

JLS1 profile image
JLS1
1 Reply

Is anyone in this trial? It sounds promising!

A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

clinicaltrials.gov/ct2/show...

businesswire.com/news/home/...

Written by
JLS1 profile image
JLS1
To view profiles and participate in discussions please or .
Read more about...
1 Reply
CantChoose profile image
CantChoose

We've been offered this trial. There's next to nothing about it online. Anyone have an opinion?

Likely our last good shot at stopping this thing.

You may also like...

FDA Clearance of FK-PC101, a Novel Personalized Prostate Cancer Immunotherapy

across the US.\\"...

CCW702 - FDA clears its IND for new immunotherapeutic for treating prostate cancer Aug 21 2019

molecule in patients.\\" First-in-human Study of CCW702 in Patients With Metastatic Castration...

Apalutamide Submitted to FDA for Treatment of Metastatic Castration-Sensitive Prostate Cancer

https://www.targetedonc.com/news/apalutamide-submitted-to-fda-for-treatment-of-metastatic-castration

Active Surveillance \"v\" treatment for Early Stage Prostate Cancer

calling and e-mailing me about last weeks prostate cancer news wondering why I am not on active...

FDA Grants Fast Track Designation for 177Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer

ce-FDA-Grants-Fast-Track-Designation-for-177Lu-PNT2002-for-the-Treatment-of-Metastatic-Castration-Re